Study identified a drug for potential use in future precision medicine clinical trials

CHOP’s Leukodystrophy Center, one of the leading centers of its kind in the nation, now offers Lenmeldy to treat children with metachromatic leukodystrophy (MLD). 

Researchers at Children’s Hospital of Philadelphia (CHOP) found that most patients and their families who reported experiencing food insecurity benefitted from consistent delivery of fresh produce and prepared healthy meals post-hospitalization. The study, recently published in Pediatrics, underscores the need for hospital systems to partner with community-based organizations to address food insecurity throughout the United States.

Researchers at Children’s Hospital of Philadelphia (CHOP) announced the creation of a new AI technology called CelloType, a comprehensive model designed to more accurately identify and classify cells in high-content tissue images. The findings were published today in the journal Nature Methods.

Find a report about the effectiveness of nirsevimab in preventing severe RSV illness in Alaska Native children. Learn about a recent CDC podcast focused on health communication, and see which VISs were recently updated.

Learn how to better communicate ideas using the authors’ SUCCESs approach. Ideas that are Simple, Unexpected, Concrete, Credible, Emotional, and told through Stories are “made to stick.” Read about how Dr. Offit applied this approach in a memorable demonstration.

As Vaccines for Children (VFC) celebrates 30 years of protecting children from vaccine-preventable diseases, Mary Beth Koslap-Petraco, one of the first VFC coordinators in New York, shares her reflections on the start of the program.

Find out about a study of a live attenuated intranasal pertussis vaccine, including the findings compared with current pertussis vaccines.

Read about the roles of the U.S. federal, state and local governments in implementing vaccine policy and find four areas where individuals can affect change.

Researchers at Children’s Hospital of Philadelphia (CHOP) announced the launch of the initial phase of DISCOVERY of Risk Factors for Type 2 Diabetes in Youth, a nationwide National Institute of Health (NIH) study to address the surge in youth diagnosed with type 2 diabetes over the past two decades.